Clinical Trial Update: A Pharmacokinetic and Efficacy Study of Amonafide L-malate (AS1413) in Combination With Cytarabine in Patients With Acute Myeloid Leukemia (AML) [Phase 2]

View source ↗

Summary

Phase 2 pharmacokinetic and efficacy study evaluating Amonafide L-malate (AS1413) in combination with Cytarabine for acute myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Amonafide L-malate (AS1413) (amonafide L-malate)
• CYTARABINE (CYTARABINE)

Snippet

Sponsor: Antisoma Research | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: UNKNOWN